Your DNA Is Constantly Moving and Folding — And Scientists Just Found Out This Is Why Cancer Happens

A new study reveals human DNA is constantly shifting and folding, not static. This dynamic structure controls gene activation — and its disruption explains how cancer develops.

The image of DNA that most people carry from school biology — a fixed double helix encoding a static set of instructions — is, a new study reveals, profoundly wrong in a specific and important way. Human DNA is not a static blueprint. It is a constantly shifting, folding, and rearranging structure whose dynamic behaviour is as important to how cells function as the specific sequence of its letters.

The research, published in the first week of April 2026 by a consortium of molecular biology groups from the UK, Switzerland, and South Korea, used a new generation of imaging technology to visualise DNA structure in living cells in real time — something that previous methods could only approximate through snapshots of fixed cells. What they found contradicts decades of cellular biology's implicit assumption that DNA structure is relatively stable between cell division events.

Instead, DNA in actively functioning cells is in constant motion — specific regions loop out from the main chromosomal structure, make contact with distant regions of the same chromosome or other chromosomes, and then retract. These contacts, which last milliseconds to seconds, activate and suppress gene expression with specificity that the DNA sequence alone cannot explain. The 'same' DNA, in cells that are identical in sequence, produces different gene expression patterns depending on which dynamic contacts are being made at any given moment.

The cancer connection is direct. Many cancer-causing mutations, the research shows, do not work by directly activating oncogenes or suppressing tumour suppressors in the conventional sense. Instead, they disrupt the regulatory elements that control which DNA-DNA contacts are made, causing genes to be expressed inappropriately or suppressed when they should be active. This mechanism — 'topological dysregulation' is the technical term — explains a category of cancer mutations that previous models couldn't account for.

The therapeutic implication is specific: drugs that target the proteins controlling DNA folding dynamics, rather than the genes themselves, represent a category of cancer treatment whose effectiveness the current understanding suggested was limited but that the new mechanism suggests might be substantial.